X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
1. Dichlofenal
2. Diclofenac
3. Diclofenac Sodium
4. Diclofenac, Sodium
5. Diclonate P
6. Diclophenac
7. Dicrofenac
8. Feloran
9. Gp 45,840
10. Gp-45,840
11. Gp45,840
12. Novapirina
13. Orthofen
14. Orthophen
15. Ortofen
16. Sodium Diclofenac
17. Sr 38
18. Sr-38
19. Sr38
20. Voltaren
21. Voltarol
1. 15307-81-0
2. Cataflam
3. Cgp 45840b
4. Voltfast
5. Cambia
6. Zipsor
7. Diclofenac Potassium [usan:usp]
8. Potassium Diclofenac
9. Potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate
10. Diclofenac (potassium)
11. Cgp-45840b
12. Diclofenac Potassium Salt
13. L4d5ua6cb4
14. Chebi:4508
15. Benzeneacetic Acid, 2-((2,6-dichlorophenyl)amino)-, Monopotassium Salt
16. Potassium 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate
17. Cataflam; Diclofenac Potassium; K-fenak; Potassium Diclofenac; Prosorb
18. Diclofenac Potassium [usan]
19. Unii-l4d5ua6cb4
20. Cataflam (tn)
21. Potassium (o-(2,6-dichloroanilino)phenyl)acetate
22. Cambia (tn)
23. Zipsor (tn)
24. Diclofenac Potassium (usp)
25. Schembl40784
26. Chembl1200804
27. Dtxsid30165212
28. Hms3656d18
29. Diclofenac Potassium [vandf]
30. Diclofenac Potassium [mart.]
31. S3062
32. Diclofenac Potassium [usp-rs]
33. Diclofenac Potassium [who-dd]
34. Akos015889752
35. Akos015994733
36. Diclofenac Potassium Salt [mi]
37. Ccg-267848
38. Ks-5037
39. Ac-18735
40. Diclofenac Potassium [orange Book]
41. Hy-15038
42. Diclofenac Potassium [ep Monograph]
43. Db-043176
44. Diclofenac Potassium [usp Monograph]
45. Cs-0003712
46. Ft-0603076
47. Sw196404-4
48. D00903
49. Q27106401
50. Potassium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate
51. Potassium 2-(2-(2,6-dichlorophenylamino)phenyl)acetate
52. Potassium (o-((2,6-dichlorophenyl)amino)phenyl)acetate
53. 2-((2,6-dichlorophenyl)amino)benzeneacetic Acid, Monopotassium Salt
| Molecular Weight | 334.2 g/mol |
|---|---|
| Molecular Formula | C14H10Cl2KNO2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 332.9725654 g/mol |
| Monoisotopic Mass | 332.9725654 g/mol |
| Topological Polar Surface Area | 52.2 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 310 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 8 | |
|---|---|
| Drug Name | Cambia |
| Drug Label | CAMBIA (Diclofenac Potassium for Oral Solution) is a benzeneacetic acid derivative NSAID. CAMBIA is available as a buffered soluble powder, designed to be mixed with water prior to oral administration. CAMBIA is a white to off-white, buff... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | For solution |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Depomed |
| 2 of 8 | |
|---|---|
| Drug Name | Cataflam |
| PubMed Health | Diclofenac |
| Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
| Drug Label | Cataflam (diclofenac potassium immediate-release tablets) is a benzeneacetic acid derivative. Cataflam is available as immediate-release tablets of 50 mg (light brown) for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benz... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Novartis |
| 3 of 8 | |
|---|---|
| Drug Name | Diclofenac potassium |
| Drug Label | Diclofenac potassium tablets USP are a benzeneacetic acid derivative. Diclofenac potassium tablets USP, 50 mg are available as orange, film-coated tablets for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid,... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Teva; Apotex; Sandoz; Mylan |
| 4 of 8 | |
|---|---|
| Drug Name | Zipsor |
| PubMed Health | Diclofenac |
| Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
| Drug Label | Zipsor (diclofenac potassium) Liquid Filled Capsule is a benzeneacetic acid derivative NSAID. Zipsor is available as liquid-filled capsules of 25 mg for oral administration. The chemical name is 2-[(2,6- dichlorophenyl) amino] benzeneacetic acid mono... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 25mg |
| Market Status | Prescription |
| Company | Depomed |
| 5 of 8 | |
|---|---|
| Drug Name | Cambia |
| Drug Label | CAMBIA (Diclofenac Potassium for Oral Solution) is a benzeneacetic acid derivative NSAID. CAMBIA is available as a buffered soluble powder, designed to be mixed with water prior to oral administration. CAMBIA is a white to off-white, buff... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | For solution |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Depomed |
| 6 of 8 | |
|---|---|
| Drug Name | Cataflam |
| PubMed Health | Diclofenac |
| Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
| Drug Label | Cataflam (diclofenac potassium immediate-release tablets) is a benzeneacetic acid derivative. Cataflam is available as immediate-release tablets of 50 mg (light brown) for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benz... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Novartis |
| 7 of 8 | |
|---|---|
| Drug Name | Diclofenac potassium |
| Drug Label | Diclofenac potassium tablets USP are a benzeneacetic acid derivative. Diclofenac potassium tablets USP, 50 mg are available as orange, film-coated tablets for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid,... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Teva; Apotex; Sandoz; Mylan |
| 8 of 8 | |
|---|---|
| Drug Name | Zipsor |
| PubMed Health | Diclofenac |
| Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
| Drug Label | Zipsor (diclofenac potassium) Liquid Filled Capsule is a benzeneacetic acid derivative NSAID. Zipsor is available as liquid-filled capsules of 25 mg for oral administration. The chemical name is 2-[(2,6- dichlorophenyl) amino] benzeneacetic acid mono... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 25mg |
| Market Status | Prescription |
| Company | Depomed |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
Market Place
